Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol dose-finding for neonatal intubation
NCT01621373Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Aug 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of propofol injection (veterinary) in neonatal condition, sponsored by UZ Leuven. Primary endpoint: Effective Dose for 50% of Patients for Successful Intubation and Subsequent Extubation in Case of Planned Extubation After INSURE Procedure. Started Aug 2012; status: completed.
02
Drugs
propofol injection (veterinary)
03
Conditions
neonatal condition
Beyond the preview
Go deeper on NCT01621373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01621373.